Please login to the form below

Not currently logged in
Email:
Password:

beloranib

This page shows the latest beloranib news and features for those working in and with pharma, biotech and healthcare.

Second patient death in Zafgen's obesity drug trial

A second patient enrolled in a phase III trial of Zafgen's obesity drug candidate beloranib has died, placing the future of the programme in doubt. ... Analysts suggested that the toxicity concern could give beloranib a tough time getting through

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics